Showing results (351-360 of 3,787) with videos related to

Sort By:
Pageof 379
Oncoimmunology|March 3, 2020
S100A4 promotes hepatocellular carcinogenesis by intensifying fibrosis-associated cancer cell stemnessYanan Li, Jun Wang, Kun Song, et al.
Oncoimmunology|March 3, 2020
Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitorsSonja C S Simon, Xiaoying Hu, Jasper Panten, et al.
Oncoimmunology|March 12, 2020
Deep neural network classification based on somatic mutations potentially predicts clinical benefit of immune checkpoint blockade in lung adenocarcinomaJie Peng, Dan Zou, Wuxing Gong, et al.
Oncoimmunology|December 8, 2018
Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trialsQingyuan Huang, Hua Zhang, Josephine Hai, et al.
Oncoimmunology|December 8, 2018
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cellsGaetano Donofrio, Giulia Tebaldi, Stefania Lanzardo, et al.
Oncoimmunology|December 8, 2018
Immune T cells can transfer and boost anti-breast cancer immunityArchana Thakur, Ritesh Rathore, Sri Vidya Kondadasula, et al.
Oncoimmunology|December 8, 2018
Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinomaKevin W Ng, Erin A Marshall, Katey Ss Enfield, et al.
Oncoimmunology|December 8, 2018
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survivalMarcelo Sobral-Leite, Koen Van de Vijver, Magali Michaut, et al.
Oncoimmunology|December 8, 2018
miR-17-5p-CXCL14 axis related transcriptome profile and clinical outcome in diffuse gliomasAiliang Zeng, Jianxin Yin, Zheng Wang, et al.
Oncoimmunology|February 1, 2020
Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patientsTuba N Gide, Ines P Silva, Camelia Quek, et al.
Pageof 379